i10 Productivity
Rankings
M D University ScientistsOthers i10 Productivity Rankings 2025
Productivity Rankings is an exclusive service provided by AD Scientific Index. This ranking system, derived from the i10 index, highlights the productivity of scientists in publishing impactful scientific articles. Productivity Rankings serves as a tool to identify highly productive scientists across specific areas, disciplines, universities, and countries, and supports the creation of effective incentives and academic policies. The global, regional, and institutional rankings of scientists in this table are calculated based on their total i10 index. Moreover, you can explore special rankings derived from Productivity Rankings, such as Scientists Last 6 Years' i10 Index, Universities Total i10 Index Rankings 2025, Universities Last 6 Years' i10 Index Rankings 2025, Art and Humanities i10 Productivity Rankings, and Social Sciences and Humanities i10 Productivity Rankings.
* Total i10 IndexRankings
Ranking Based On Selection :201
Renal physiology Medical education Rare diseases Calcium & water homeostasis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
19
0.950
* Total i10 IndexRankings
Ranking Based On Selection :202
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
19
0.950
* Total i10 IndexRankings
Ranking Based On Selection :203
Drug discovery
Clinical biomarker
Target validation
biomarker discovery
translational biology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
18
0.900
* Total i10 IndexRankings
Ranking Based On Selection :204
Radiation biology
particle therapy
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
18
0.900
* Total i10 IndexRankings
Ranking Based On Selection :205
9 color opal staining
vectra Polaris
Leica Bond RX
oncology biomarker
Renal Cell Carcinoma
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
16
0.800
* Total i10 IndexRankings
Ranking Based On Selection :206
Cancer Prevention Research
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
15
0.750
* Total i10 IndexRankings
Ranking Based On Selection :207
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
15
0.750
* Total i10 IndexRankings
Ranking Based On Selection :208
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
19
1.000
* Total i10 IndexRankings
Ranking Based On Selection :209
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
18
0.947
* Total i10 IndexRankings
Ranking Based On Selection :210
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
17
0.895
* Total i10 IndexRankings
Ranking Based On Selection :211
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
16
0.842
* Total i10 IndexRankings
Ranking Based On Selection :212
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
16
0.842
* Total i10 IndexRankings
Ranking Based On Selection :213
Scientific Computation
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
16
0.842
* Total i10 IndexRankings
Ranking Based On Selection :214
cancer
breast cancer
RabGTPases
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
14
0.737
* Total i10 IndexRankings
Ranking Based On Selection :215
ADP-ribosylation and poly(ADP-ribose)-binding
Post-translational modification
cancer biology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
18
1.000
* Total i10 IndexRankings
Ranking Based On Selection :216
Skeletal muscle physiology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
18
1.000
* Total i10 IndexRankings
Ranking Based On Selection :217
Science
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
* Total i10 IndexRankings
Ranking Based On Selection :218
NGS
Leukemia
Immunology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
* Total i10 IndexRankings
Ranking Based On Selection :219
Cell cycle
DNA repair
kinase
PARP
Resistance
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
* Total i10 IndexRankings
Ranking Based On Selection :220
Dysproteinemias and lymphoproliferative disorders
multiple myeloma
amyloidosis
lymphoma
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
* Total i10 IndexRankings
Ranking Based On Selection :221
Inflammatory breast cancer/TNBC
signal transduction
clinical trials/therapeutics
cell cycle
resistance
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
* Total i10 IndexRankings
Ranking Based On Selection :222
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
* Total i10 IndexRankings
Ranking Based On Selection :223
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
* Total i10 IndexRankings
Ranking Based On Selection :224
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
* Total i10 IndexRankings
Ranking Based On Selection :225
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
Jean Philippe Bertocchio
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
19
0.950
Renal physiology Medical education Rare diseases Calcium & water homeostasis
Reza Reiazi
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
19
0.950
Yuting Sun
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
18
0.900
Drug discovery
Clinical biomarker
Target validation
biomarker discovery
translational biology
Lawrence Bronk
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
18
0.900
Lijun Zhou
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
16
0.800
9 color opal staining
vectra Polaris
Leica Bond RX
oncology biomarker
Renal Cell Carcinoma
Lisa T Wigfall
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
15
0.750
Mei Yang
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
20
15
0.750
Chen Zhang
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
19
1.000
Mayela Mendt
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
18
0.947
Mary Catherine Mareno
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
17
0.895
Jan H Reiling
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
16
0.842
Son JB
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
16
0.842
Nan Chen
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
16
0.842
Shreya Mitra
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
19
14
0.737
Nan Li
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
18
1.000
ADP-ribosylation and poly(ADP-ribose)-binding
Post-translational modification
cancer biology
J Andrew Livingston *
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
18
1.000
Mauro Di Pilato
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
Yanqing Huang
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
Mei Kuang Chen
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
Gregory P Kaufman
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
17
0.944
Dysproteinemias and lymphoproliferative disorders
multiple myeloma
amyloidosis
lymphoma
Angela Alexander
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
Inflammatory breast cancer/TNBC
signal transduction
clinical trials/therapeutics
cell cycle
resistance
Jenolyn F Alexander
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
Piotr Dorniak
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
Pranoti Sahasrabhojane
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
Mingxuan Xu
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889